ResMed Inc (RMD)

Debt-to-equity ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 5,967,860 5,546,130 5,253,010 5,195,030 4,864,040 4,629,920 4,481,850 4,250,380 4,129,900 3,932,510 3,738,130 3,432,890 3,360,750 3,278,800 3,145,840 3,026,050 2,885,680 2,709,230 2,864,980 2,678,860
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

June 30, 2025 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $5,967,860K
= 0.00

The data indicates that ResMed Inc. has maintained a debt-to-equity ratio of zero across all reported periods from September 30, 2020, through June 30, 2025. This consistent value suggests that the company has not employed any long-term or short-term debt financing during this timeframe. Consequently, ResMed’s financial structure appears to be entirely equity-financed, reflecting a conservative approach to leverage and debt management. The absence of debt-related activity indicates that the company relies solely on shareholders' equity for funding its operations and investments, which may influence its financial flexibility, risk profile, and cost of capital considerations.